Federal Supply Schedule 36F79720D0179
Award Date
8/1/20
Last Date to Order
1/31/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Blueprint Medicines Corporation
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB, which covers Drugs, Pharmaceuticals, and Hematology Related Products. The contract was awarded to HLS Therapeutics Inc., a for-profit manufacturer, on July 1, 2022 by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract has a ceiling value of $13,848,500.00 and a period of performance through June 30, 2027. It is a multiple award...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded to Array Biopharma Inc. by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs. The contract has a ceiling value of $3,309,320.00 and a period of performance through June 30, 2024. The contract provides for the delivery of pharmaceuticals, drugs, and hematology-related products to support the healthcare needs of...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 IB for Drugs, Pharmaceuticals, and Hematology Related Products, awarded by the Department of Veterans Affairs (VA) to Heritage Pharmaceuticals Inc., doing business as Avet Pharmaceuticals Inc. The contract has a ceiling value of $25,000 and a period of performance through April 2023. Additionally, Heritage Pharmaceuticals holds a separate $1.5 million FSS Schedule 65 IB contract with the VA that runs...
The federal contract IDV award is a multiple award Federal Supply Schedule under the Pharmaceuticals and Drugs master schedule. The prime contractor is Epizyme, Inc., doing business as Epizyme. The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 is the contracting agency. The contract aims to procure drugs, pharmaceuticals, and hematology-related products through June 2023 for a potential value of $225,000. No set-asides were used. The...
This federal contract IDV award is for a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, held by Pharmacyclics LLC, an AbbVie company. The contract has a ceiling value of $761,600,000 and a period of performance through August 28, 2025. The contract vehicle is intended to provide the Department of Veterans Affairs and its Veterans Integrated Service Network 12 with a diverse selection of drugs, pharmaceuticals, and hematology-related products....
The federal contract IDV award described is a Federal Supply Schedule (FSS) contract under Schedule 65 I B Drugs, Pharmaceuticals, & Hematology Related Products, awarded to Syndax Pharmaceuticals, Inc. by the Department of Veterans Affairs. The contract has a ceiling value of $25,000.00 and a period of performance from February 1, 2025 to July 31, 2025. The contract aims to procure various pharmaceutical products and hematology-related supplies for the Veterans Integrated Service Network 12....
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under Schedule 65 I B for Drugs, Pharmaceuticals, & Hematology Related Products. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 12 (VISN 12). The prime contractor is Reata Pharmaceuticals, Inc., a for-profit organization. The contract has a ceiling value of $25,000.00 and a period of performance ending on October 23, 2023. It is a multiple...
The federal contract IDV award is a Federal Supply Schedule contract with the Department of Veterans Affairs to provide pharmaceutical and hematology-related products. The 5-year, $250,000 multiple award IDV enables VA medical centers in Veterans Integrated Service Network 12 to procure hematology products without separate solicitations. The prime contractor is 60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company that develops and commercializes infectious disease medicines. 60...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract (36F79722D0202) awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 12 to CTI Biopharma Corp. (doing business as CTI Biopharma), a for-profit manufacturer of drugs, pharmaceuticals, and hematology-related products. The multiple-award contract has a ceiling value of $3,000,000 and an ultimate completion date of October 31, 2027. This FSS contract under...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36F79720D0179-36C26021F0017 | Blueprint Medicines Corporation | $0 | 10/1/20 | 10/16/20 | 10/15/20 |